PYGB and nervous system disorder: Its identification as a brain glycogen phosphorylase activator (Kd = 0.32 μM) [10] positions it uniquely among natural products, which more commonly inhibit this enzyme, and suggests potential therapeutic applications in neurological disorders characterized by glycogen accumulation [41].